Thornal will join the orthopedics company as group president for global businesses and the Americas, a newly created position ...

Zimmer Biomet announced today that it appointed Kevin Thornal as group president, global businesses and the Americas.

Zimmer Biomet named Kevin Thornal as group president for global business and the Americas, according to a May 27 news release. Mr. Thornal will join the company July 1. He was previously CEO and ...

From new partnerships and launches, here are six developments from Globus Medical so far in 2025. 1. OsteoCentric Technologies entered into a non-exclusive licensing agreement with Globus Medical.

StockNews.com began coverage on shares of Nevro (NYSE:NVRO – Free Report) in a report published on Saturday morning. The brokerage issued a hold rating on the medical equipment provider’s stock.

REDWOOD CITY, Calif., March 4, 2025 /PRNewswire/ — Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of ...

Nevro routinely posts information that may be important to investors in the "Investor Relations" section of its website at www.nevro.com. The company encourages investors and potential investors ...

Nevro Corp. NVRO reported a loss per share of 70 cents in the first quarter of 2024 compared with the year-ago quarter’s loss of 98 cents. The metric beat the Zacks Consensus Estimate by 31.37%.

After inking a deal worth up to $75 million to acquire joint pain devicemaker Vyrsa Technologies late last year, Nevro now appears to be trying to lessen the impact of those costs on its bottom line.

Nevro Corp.’s stock NVRO rose by 0.3% in premarket trades on Tuesday after the Redwood City, Calif.-based medical device maker said it would reduce its work force by 5% or 63 people. The company ...